Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients
- 1 May 1977
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 93 (5), 585-591
- https://doi.org/10.1016/s0002-8703(77)80008-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- THE EFFECTS OF ORAL AH 5158, A COMBINED α AND β-ADRENOCEPTOR ANTAGONIST, IN HEALTHY VOLUNTEERSBritish Journal of Clinical Pharmacology, 1974
- Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.Heart, 1974
- ??-Adrenergic Receptor Blocking Drugs in HypertensionDrugs, 1974
- Pharmacology of AH 5158; a drug which blocks both α‐ and β‐adrenoceptorsBritish Journal of Pharmacology, 1972
- Clinical investigation of an antagonist at α‐ and β‐adrenoceptors‐AH 5158ABritish Journal of Pharmacology, 1972
- Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive manThe American Journal of Cardiology, 1971
- Relations between pressure in pulmonary artery, left atrium, and left ventricle with special reference to events at end diastole.Heart, 1971
- SIMPLIFIED METHOD FOR PERCUTANEOUS ARTERIAL CATHETERISATIONThe Lancet, 1971
- New treatment for hypertensionEuropean Journal of Clinical Pharmacology, 1971
- Roentgenological Heart Volume Determination with Special Regard to Pulse Rate and the Position of the BodyActa Radiologica, 1948